Detalhe da pesquisa
1.
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study.
Oncology
; 79(5-6): 415-22, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21474966
2.
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
Int J Cancer
; 125(1): 235-43, 2009 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19358275
3.
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Anticancer Res
; 29(5): 1841-5, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19443414
4.
Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: report of a case.
Surg Today
; 39(4): 335-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19319643
5.
A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.
Oncology
; 75(3-4): 175-81, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18841031
6.
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide.
J Clin Oncol
; 23(28): 6908-18, 2005 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16129844
7.
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.
J Clin Oncol
; 23(22): 4866-75, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15939922
8.
Clinical trials.
Front Biosci
; 11: 2918-23, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16720363
9.
Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
Lung Cancer
; 52(2): 199-206, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16542747
10.
Increasing single epirubicin doses in advanced soft tissue sarcomas.
J Clin Oncol
; 20(5): 1329-34, 2002 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11870176
11.
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.
J Clin Oncol
; 20(11): 2689-94, 2002 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12039931
12.
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.
J Clin Oncol
; 21(18): 3462-8, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12972521
13.
Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells.
Cancer Biol Ther
; 4(8): 866-71, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16210917
14.
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.
Anticancer Res
; 25(2B): 1309-14, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15865083
15.
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study.
Semin Oncol
; 31(2 Suppl 5): 13-9, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15199527
16.
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.
Anticancer Res
; 22(5): 3045-51, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12530040
17.
Paraneoplastic Raynaud phenomenon with digital necrosis associated with hyperhomocysteinemia and antiphospholipid antibodies.
Arch Dermatol
; 143(10): 1342-3, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17938361
18.
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
Cancer Chemother Pharmacol
; 67(3): 687-93, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20512334
19.
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.
Int J Oncol
; 39(4): 1011-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21720704
20.
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
J Exp Clin Cancer Res
; 30: 39, 2011 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21481280